Though in this work, we employ NAMPT inhibition as a strategy to enhance CtBP inhibition, NAMPT has been extensively pursued as a cancer therapeutic target, as certain tumors exhibit absolute dependency on the NAD salvage pathway due to the absence of functional de novo or PH pathways (4). The gene discussed is NAMPT; the disease is cancer.